These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1936483)

  • 1. Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients.
    Klein W
    Diabete Metab; 1991 May; 17(1 Pt 2):235-40. PubMed ID: 1936483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
    Umpierrez G; Issa M; Vlajnic A
    Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
    Drzewoski J; Czupryniak L
    Med Sci Monit; 2003 Jun; 9(6):CR240-3. PubMed ID: 12824953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
    Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
    Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly).
    Lalau JD; Vermersch A; Hary L; Andrejak M; Isnard F; Quichaud J
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):329-32. PubMed ID: 2272714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea.
    Mari A; Nielsen LL; Nanayakkara N; DeFronzo RA; Ferrannini E; Halseth A
    Horm Metab Res; 2006 Dec; 38(12):838-44. PubMed ID: 17163361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of type 2 diabetes mellitus with special reference to metformin therapy.
    Campbell IW
    Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.
    Rascati KL; Richards KM; Lopez D; Cheng LI; Wilson JP
    Clin Ther; 2011 Dec; 33(12):2016-20. PubMed ID: 22101160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic management of the secondary failure of sulfonylurea therapy].
    Sauer H
    Dtsch Med Wochenschr; 1985 Jan; 110(1):27-30. PubMed ID: 3880697
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed-time NPH insulin to glyburide.
    Vigneri R; Trischitta V; Italia S; Mazzarino S; Rabuazzo MA; Squatrito S
    Diabete Metab; 1991 May; 17(1 Pt 2):232-4. PubMed ID: 1936482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of metformin versus guar in combination with sulphonylureas in the treatment of non insulin dependent diabetes.
    Wilson JA; Scott MM; Gray RS
    Horm Metab Res; 1989 Jun; 21(6):317-9. PubMed ID: 2777189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
    Groop L; Widén E
    Diabete Metab; 1991 May; 17(1 Pt 2):218-23. PubMed ID: 1936480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes.
    Teupe B; Bergis K
    Diabete Metab; 1991 May; 17(1 Pt 2):213-7. PubMed ID: 1936479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination daytime chlorpropamide-metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes.
    Aguilar CA; Wong B; Gómez-Pérez FJ; Rull JA
    Rev Invest Clin; 1992; 44(1):71-6. PubMed ID: 1523352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.